JILLIAN GRZEGORCZYK: Open Payments
NPI 1942789805 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 20 payments from 11 companies in 2025. Trend: 2023 $560 · 2024 $348 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $138 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| Kestra Medical Technology Services, Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| CORDIS US CORP. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: CARDIOMEMS, LEQVIO, Assure WCD, ELIQUIS, FUROSCIX, CAMZYOS, UPTRAVI, Attruby.
Industry payments across MI — which companies pay providers there.
